Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0455T
|
Removal of permanently implantable aortic counterpulsation ventricular assist system; complete system (aortic counterpulsation device vascular hemostatic seal mechano-electrical skin interface and electrodes)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0455U
|
Infectious agents (sexually transmitted infection) Chlamydia trachomatis Neisseria gonorrhoeae and Trichomonas vaginalis multiplex amplified probe technique vaginal endocervical gynecological specimens oropharyngeal swabs rectal swabs female or male urine each pathogen reported as detected or not detected
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0456T
|
Removal of permanently implantable aortic counterpulsation ventricular assist system; aortic counterpulsation device and vascular hemostatic seal
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0456U
|
Autoimmune (rheumatoid arthritis) next-generation sequencing (NGS) gene expression testing of 19 genes whole blood with analysis of anti-cyclic citrullinated peptides (CCP) levels combined with sex patient global assessment and body mass index (BMI) algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0457T
|
Removal of permanently implantable aortic counterpulsation ventricular assist system; mechano-electrical skin interface
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0457U
|
Perfluoroalkyl substances (PFAS) (eg perfluorooctanoic acid perfluorooctane sulfonic acid) 9 PFAS compounds by LC-MS/MS plasma or serum quantitative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0458T
|
Removal of permanently implantable aortic counterpulsation ventricular assist system; subcutaneous electrode
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0458U
|
Oncology (breast cancer) S100A8 and S100A9 by enzyme-linked immunosorbent assay (ELISA) tear fluid with age algorithm reported as a risk score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0459T
|
Relocation of skin pocket with replacement of implanted aortic counterpulsation ventricular assist device mechano-electrical skin interface and electrodes
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0459U
|
B-amyloid (Abeta42) and total tau (tTau) electrochemiluminescent immunoassay (ECLIA) cerebral spinal fluid ratio reported as positive or negative for amyloid pathology
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0460T
|
Repositioning of previously implanted aortic counterpulsation ventricular assist device; subcutaneous electrode
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0460U
|
Oncology whole blood or buccal DNA single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes with variant analysis and reported phenotypes
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0461T
|
Repositioning of previously implanted aortic counterpulsation ventricular assist device; aortic counterpulsation device
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0461U
|
Oncology pharmacogenomic analysis of single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes whole blood or buccal swab with variant analysis including impacted gene-drug interactions and reported phenotypes
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0462T
|
Programming device evaluation (in person) with iterative adjustment of the implantable mechano-electrical skin interface and/or external driver to test the function of the device and select optimal permanent programmed values with analysis including review and report implantable aortic counterpulsation ventricular assist system per day
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0462U
|
Melatonin levels test sleep study 7 or 9 sample melatonin profile (cortisol optional) enzyme-linked immunosorbent assay (ELISA) saliva screening/preliminary
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0463T
|
Interrogation device evaluation (in person) with analysis review and report includes connection recording and disconnection per patient encounter implantable aortic counterpulsation ventricular assist system per day
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0463U
|
Oncology (cervix) mRNA gene expression profiling of 14 biomarkers (E6 and E7 of the highest-risk human papillomavirus [HPV] types 16 18 31 33 45 52 58) by real-time nucleic acid sequence-based amplification (NASBA) exo- or endocervical epithelial cells algorithm reported as positive or negative for increased risk of cervical dysplasia or cancer for each biomarker
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0464T
|
Visual evoked potential testing for glaucoma with interpretation and report
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0464U
|
Oncology (colorectal) screening quantitative real-time target and signal amplification methylated DNA markers including LASS4 LRRC4 and PPP2R5C a reference marker ZDHHC1 and a protein marker (fecal hemoglobin) utilizing stool algorithm reported as a positive or negative result
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.